Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8945
Corporate User License Price USD 375
Corporate User License Price INR 26835
Site License Price USD 250
Site License Price INR 17890
Request a Quote

Report Title

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review



Executive Summary

Granules India Ltd (GRANULES)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Granules India Ltd (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With offices in India, the US, the UK, China and Colombia, the company offers products and solutions to companies across the world. Granules also provides contract research and manufacturing services. Its key clients include leading generic and branded pharmaceutical companies. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Ltd Key Recent Developments

May 24,2018: Granules India's Total Income increases by 18% to INR 1,703 Cr

Mar 26,2018: Granules India's Gagillapur and Jeedimetla facilities complete US FDA inspection

Feb 28,2018: Granules India's Chantilly facility received EIR from USFDA

Feb 08,2018: Granules India's Revenue from operation increases by 14% to INR 411 Cr

Nov 09,2017: Granules India's Revenue from operation increases by 8% to INR 393 Cr

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Granules India Ltd-Key Facts 6

Granules India Ltd-Key Employees 7

Granules India Ltd-Key Employee Biographies 8

Granules India Ltd-Major Products and Services 9

Granules India Ltd-History 10

Granules India Ltd-Company Statement 11

Granules India Ltd-Locations And Subsidiaries 13

Head Office 13

Other Locations & Subsidiaries 13

Joint Venture 13

Section 2-Company Analysis 14

Company Overview 14

Granules India Ltd-Business Description 15

Granules India Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

Granules India Ltd-Strengths 16

Granules India Ltd-Weaknesses 17

Granules India Ltd-Opportunities 18

Granules India Ltd-Threats 19

Granules India Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Granules India Ltd, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 24, 2018: Granules India's Total Income increases by 18% to INR 1,703 Cr 31

Mar 26, 2018: Granules India's Gagillapur and Jeedimetla facilities complete US FDA inspection 32

Feb 28, 2018: Granules India's Chantilly facility received EIR from USFDA 33

Feb 08, 2018: Granules India's Revenue from operation increases by 14% to INR 411 Cr 34

Nov 09, 2017: Granules India's Revenue from operation increases by 8% to INR 393 Cr 35

Oct 06, 2017: Receipt of establishment report by Granules OmniChem facility from US FDA 36

Aug 16, 2017: Granules India Reports Establishment Inspection Report (EIR) From US FDA-Reg. 37

Aug 14, 2017: Granules India Reported Its First Quarter Financial Results 2017 38

May 11, 2017: Granules India's Revenue increases 4% to Rs. 1,435 Cr.; Net Profit surges 34% to Rs. 165 Cr 39

Feb 03, 2017: Granules India's Gagillapur facility completed INFARMED reinspection 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Granules India Ltd, Performance Chart (2014-2018) 25

Granules India Ltd, Ratio Charts 27

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Granules India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

Granules India Ltd, Key Facts 6

Granules India Ltd, Key Employees 7

Granules India Ltd, Key Employee Biographies 8

Granules India Ltd, Major Products and Services 9

Granules India Ltd, History 10

Granules India Ltd, Subsidiaries 13

Granules India Ltd, Joint Venture 13

Granules India Ltd, Key Competitors 20

Granules India Ltd, Ratios based on current share price 21

Granules India Ltd, Annual Ratios 22

Granules India Ltd, Annual Ratios (Cont...1) 23

Granules India Ltd, Annual Ratios (Cont...2) 24

Granules India Ltd, Interim Ratios 26

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Granules India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Granules India Ltd, Recent Deals Summary 30

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Aditya Birla Chemicals (India) Ltd

Atul Ltd

BASF India Ltd

Divi's Laboratories Ltd

Hikal Ltd

Ind-Swift Laboratories Ltd

Suven Life Sciences Ltd

Teva Pharmaceutical Industries Ltd

Granules India Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand